sr-147778 and Obesity

sr-147778 has been researched along with Obesity* in 1 studies

1 review(s) available for sr-147778 and Obesity

Article	Year
Will the new CB1 cannabinoid receptor antagonist SR-147778 have advantages over rimonabant? Expert opinion on investigational drugs, 2005, Volume: 14, Issue:3 Topics: Alcoholism; Animals; Humans; Obesity; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant	2005